Skip to content
  • About
  • R&D
  • News/Media
  • Ethics
  • Support
  • About
  • R&D
  • News/Media
  • Ethics
  • Support
  • Company Overview
  • Milestones
  • Directions
  • Company Overview
  • Milestones
  • Directions
  • Pipeline
  • Publications
  • BiomeTreasure
  • Pipeline
  • Publications
  • BiomeTreasure
  • Press Releases
  • Media
  • Press Releases
  • Media
  • Ethical Charter
  • Anti-Corruption and Compliance Policy
  • Whistleblowing Center
  • Ethical Charter
  • Anti-Corruption and Compliance Policy
  • Whistleblowing Center
  • Announcements
  • Contact Us
  • Announcements
  • Contact Us
  • EN
    • KR
    • CN
  • EN
    • KR
    • CN

Limosilactobacillus reuteri ATG-F4 Ameliorates Dexamethasone-Induced Muscle Atrophy through Modulation of Gut Microbiota

에이투젠, 장내 미생물 활용 여성 질환 솔루션 제공

에이투젠, 체지방 감소 프로바이오틱스 식약처 개별인정 획득

에이투젠, 마이크로바이옴 소재 미국 · 유럽 특허 권리 확보

[IR52 장영실상] 식후 혈당·장 건강 한번에 잡는 K유산균

Limosilactobacillus reuteri ATG-F4 Improves the Muscle Strength and Muscle Mass of Mice with Immobilization-Induced Muscular Atrophy.

Therapeutic Potential of Lactobacillus plantarum ATG‐K2 in Bacterial Vaginosis: In Vitro and In Vivo Evidence. 2025:1-9

Single and repeated-dose toxicity studies by intravaginal administration of Lactobacillus plantarum ATG-K2 powder in female rats

Establishment of a chronic biliary disease mouse model with cholecystoduodenal anastomosis for intestinal microbiome preservation. 2024, 14;30(46):4937-4946.

Characterization and temporal dynamics of the intra-and extracellular environments of Lactiplantibacillus plantarum using multi-platform metabolomics.  2023, (175) 114376.

  • 1
  • 2
  • 3
  • 4
  • Next
From Microbiome
to Medicine
Head Office11-6, Techno 1-ro, Yuseong-gu, Daejeon, Republic of Korea
TEL.+82-42-931-8255
FAX.+82-42-935-8258
E-mailatogen@atogen.co.kr
Youtube Instagram Instagram
Copyright@ATOGEN Co., Ltd. All rights Reserved.
  • About
    • Company Overview
    • Milestones
    • Directions
  • R&D
    • Pipeline
      • Overview
      • Therapeutics
        • Overview
        • Bacterial Vaginosis
        • Oncology
        • Allergic Diseases
        • Inflammatory Diseases
        • MASH
      • Functional Probiotics
        • Overview
        • Postprandial Blood Glucose Control
        • Body Fat Reduction
        • Muscle Function & Strength
        • Immune Health
        • Women’s Vaginal Health
        • Respiratory Health Support
    • Publications
    • BiomeTreasure
  • News/Media
    • Press Releases
    • Media
  • Ethics
    • Ethical Charter
    • Anti-Corruption and Compliance Policy
    • Whistleblowing Center
  • Support
    • Announcements
    • Contact Us
  • About
    • Company Overview
    • Milestones
    • Directions
  • R&D
    • Pipeline
      • Overview
      • Therapeutics
        • Overview
        • Bacterial Vaginosis
        • Oncology
        • Allergic Diseases
        • Inflammatory Diseases
        • MASH
      • Functional Probiotics
        • Overview
        • Postprandial Blood Glucose Control
        • Body Fat Reduction
        • Muscle Function & Strength
        • Immune Health
        • Women’s Vaginal Health
        • Respiratory Health Support
    • Publications
    • BiomeTreasure
  • News/Media
    • Press Releases
    • Media
  • Ethics
    • Ethical Charter
    • Anti-Corruption and Compliance Policy
    • Whistleblowing Center
  • Support
    • Announcements
    • Contact Us